Stay updated on Modified RNA Influenza Vaccine Safety Clinical Trial
Sign up to get notified when there's something new on the Modified RNA Influenza Vaccine Safety Clinical Trial page.

Latest updates to the Modified RNA Influenza Vaccine Safety Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check16 days agoChange DetectedThe page has added a section with helpful links provided by Pfizer, specifically directing users to obtain contact information for a study center nearby.SummaryDifference0.2%
- Check23 days agoChange DetectedThe webpage has undergone significant revisions, including the removal of detailed descriptions of two substudy protocols for evaluating influenza vaccines, which are critical for understanding the study's design and participant criteria. Additionally, there are updates to the versioning of the study documentation.SummaryDifference13%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check66 days agoChange DetectedThe page has removed information regarding heavy traffic affecting NLM-NCBI services and products, as well as links to contact information for Pfizer study centers.SummaryDifference0.5%
Stay in the know with updates to Modified RNA Influenza Vaccine Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Modified RNA Influenza Vaccine Safety Clinical Trial page.